Mead Johnson Nutrition
The 10-second takeaway
For the quarter ended March 31 (Q1), Mead Johnson Nutrition beat slightly on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue grew. GAAP earnings per share grew.
Gross margins increased, operating margins dropped, net margins were steady.
Mead Johnson Nutrition reported revenue of $1.04 billion. The 11 analysts polled by S&P Capital IQ anticipated sales of $1.02 billion on the same basis. GAAP reported sales were 5.2% higher than the prior-year quarter's $986.6 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.85. The 14 earnings estimates compiled by S&P Capital IQ anticipated $0.85 per share. GAAP EPS of $0.85 for Q1 were 6.3% higher than the prior-year quarter's $0.80 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 62.3%, 20 basis points better than the prior-year quarter. Operating margin was 24.0%, 200 basis points worse than the prior-year quarter. Net margin was 16.6%, much about the same as the prior-year quarter. (Margins calculated in GAAP terms.)
Next quarter's average estimate for revenue is $1.04 billion. On the bottom line, the average EPS estimate is $0.83.
Next year's average estimate for revenue is $4.15 billion. The average EPS estimate is $3.30.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 76 members out of 92 rating the stock outperform, and 16 members rating it underperform. Among 30 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 24 give Mead Johnson Nutrition a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mead Johnson Nutrition is outperform, with an average price target of $79.29.
The rich are different than you and me: They might not notice the moneymaking stories right under our noses. In our new report, "Middle-Class Millionaire-Makers: 3 Stocks Wall Street's Too Rich to Notice," we give you three Peter Lynch-inspired buy-what-you-know stocks for the 99%. Click here for instant access to this free report.
- Add Mead Johnson Nutrition to My Watchlist.
Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor of Motley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.